Your browser doesn't support javascript.
loading
O(6) -methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide.
Cancer ; 118(18): 4545-54, 2012 Sep 15.
Article en En | MEDLINE | ID: mdl-22359215

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Regiones Promotoras Genéticas / Glioblastoma / Metilación de ADN / O(6)-Metilguanina-ADN Metiltransferasa Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2012 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Regiones Promotoras Genéticas / Glioblastoma / Metilación de ADN / O(6)-Metilguanina-ADN Metiltransferasa Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2012 Tipo del documento: Article País de afiliación: Francia